The trajectory of Sildenafil presents a challenging picture for investors. While the initial launch generated significant returns, the lapse of its patent opened the door to cheaper competitors, dramatically reducing https://socialdosa.com/story11676550/sildenafil-and-the-pharmaceutical-industry-a-volatile-bet